Pharmacoeconomic review report: Tiotropium bromide monohydrate (Spiriva respimat) for inhalation
Tiotropium bromide Soft Mist Inhaler (Spiriva Respimat; Tio R 5) is a long-acting muscarinic antagonist (LAMA) indicated as a long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis...
Corporate Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
[Ottawa, Ontario]
Canadian Agency for Drugs and Technologies in Health
July 2015, 2015
|
Series: | CADTH common drug review
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | Tiotropium bromide Soft Mist Inhaler (Spiriva Respimat; Tio R 5) is a long-acting muscarinic antagonist (LAMA) indicated as a long-term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema, and for the reduction of exacerbations. The manufacturer is requesting a listing in line with the indication. Tio R 5 is available as a multi-use cartridge containing 60 2.5 mcg actuations. As the recommended dose of Tio R 5 is two inhalations of 2.5 mcg (5 mcg) once daily, each cartridge provides a 30-day supply |
---|---|
Physical Description: | 1 PDF file (ii, 9 pages) |